3416400781

BIBLIOGRAPHIE

p53 and a temperature-sensitive mutant induce Fas/APO-1 expression. Mol Celi Biol 1995; 15: 3032-3040.

Oyama, T., Ran, S., Ishida, T., Nadaf, S., Kerr, L., Carbone, D.P. and Gabrilovich, D.I.

Vascular endothelial growth factor affects dendritic celi maturation through the inhibition of nuclear factor-kappa B activation in hemopoietic progenitor cells. J Immunol 1998; 160: 1224-1232.

Ozes, O.N., Mayo, L.D., Gustin, J.A., Pfeffer, S.R., Pfeffer, L.M. and Donner, D.B. NF-

kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Naturę 1999; 401: 82-85.

Pahl, H.L. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 1999; 18: 6853-6866.

Pahl, H.L., Krauss, B., Schulze-Osthoff, K., Decker, T., Traenckner, E.B., Vogt, M., Myers, C., Parks, T., Warring, P., Muhlbacher, A., Czernilofsky, A.P. and Baeuerle, P.A. The immunosuppressive fungal metabolite gliotoxin specifically inhibits transcription factor NF-kappaB. J Exp Med 1996; 183: 1829-1840.

Pajonk, F. and McBride, W.H. lonizing radiation affects 26s proteasome function and associated molecular responses, even at Iow doses. Radiother Oncol 2001; 59: 203-212.

Pajonk, F., Pajonk, K. and McBride, W.H. Inhibition of NF-kappaB, clonogenicity, and radiosensitivity of human cancer cells fsee comments). J Natl Cancer Inst 1999; 91: 1956-1960.

Pajonk, F., Pajonk, K. and McBride, W.H. Apoptosis and radiosensitization of hodgkin cells by proteasome inhibition [see comments|. Int J Radiat Oncol Biol Phys 2000; 47: 1025-1032.

Palombella, V.J., Rando, O.J., Goldberg, A.L. and Maniatis, T. The ubiquitin-proteasome pathway is required for processing the NF-kappa BI precursor protein and the activation of NF-kappa B. Celi 1994; 78: 773-785.

Parker, L.L., Atherton-Fcssler, S., Lee, M.S., Ogg, S., Falk, J.L., Swenson, K.I. and Piwnica-Worms, H. Cyclin promotes the tyrosine phosphorylation of p34cdc2 in a weel+ dependent manner. Embo J 1991; 10: 1255-1263.

Parker, W.B. and Cheng, Y.C. Metabolism and mechanism of action of 5-fIuorouracil. Pharmacol Ther 1990; 48: 381-395.

Patel, D., Huang, S.M., Baglia, L.A. and McCance, D.J. The E6 protein of human papillomavirus type 16 binds to and inhibits co-activation by CBP and p300. Embo J 1999; 18: 5061-5072.

Petti, L.M., Reddy, V., Smith, S.O. and DiMaio, D. Identification of amino acids in the transmembrane and juxtamembrane domains of the platelet-derived growth factor receptor required for productive interaction with the bovine papillomavirus E5 protein. JYirol 1997;71:7318-7327.

Piazza, G.A., Rahm, A.K., Finn, T.S., Fryer, B.H., Li, H., Stoumen, A.L., Pamukcu, R. and Ahnen, D.J. Apoptosis primarily accounts for the growth-inhibitory properties of sulindac metabolites and involves a mechanism that is independent of cyclooxygenase inhibition, celi cycle arrest, and p53 induction. Cancer Res 1997; 57: 2452-2459.

Pickard, M., Dive, C. and Kinsella, A.R. Differences in resistance to 5-fluorouracil as a function of celi cycle delay and not apoptosis. Br J Cancer 1995; 72: 1389-1396.

Pierce, J.W., Schoenleber, R., Jesmok, G., Best, J., Moore, S.A., Collins, T. and Gerritsen, M.E. NoveI inhibitors of cytokine-induced IkappaBalpha phosphorylation and endothelial celi adhesion molecule expression show anti-inflammatory effects in vivo. J Biol Chem 1997; 272: 21096-21103.

180